<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1807222308
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2009
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        MODODOM 1MG-1ML SUSPENSION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DOMPERIDONE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Oral suspension
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        200
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        8.4
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gulf Pharmaceutical Industries (Julphar)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A03FA03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Mododom&nbsp;</strong>is an anti-emetic which can stop you feeling sick. The active ingredient is domperidone.</p><p><strong>Mododom&nbsp;</strong>is used to relief symptoms of nausea and vomiting in adults and children.</p><p><strong>This medicine is&nbsp; for short term treatment only.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take this medicine:</strong></p><p>&bull; If you are allergic (hypersensitive) to domperidone or any of the other ingredients.Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue.</p><p>&bull; If you have a disease of the pituitary gland (prolactinoma).</p><p>&bull; If you have ever had heart problems including heart failure, a previous heart attack, angina (chest pains), or heart rhythm disorders including a rapid or slow or irregular heartbeat, without first consulting your doctor.</p><p>&bull; If you have an underlying illness affecting the digestive system, for example:</p><p>-&nbsp; A stomach or duodenal ulcer.</p><p>-&nbsp; A blocked or perforated gut.</p><p>-&nbsp; Your bowel motions (stools) are often black. This could be a sign of bleeding in the stomach or intestines.</p><p>-&nbsp; You frequently have severe stomach cramps.</p><p>&bull; If you have liver problems.</p><p>&bull; if You have a problem that gives you a low level of potassium or magnesium, or a high level of potassium in your blood.</p><p>&bull; Are taking certain medicines that slow down the metabolism (the breaking down) of other medicines in the body and can also affect your heart rhythm such as ketoconazole, fluconazole, or voriconazole, which are used to treat fungal infections, the antibiotics erythromycin, clarithromycin or telithromycin; or amiodarone, a heart medicine.<strong> </strong></p><p><strong>If any of these apply to you, get advice from a doctor or pharmacist without taking Mododom.</strong></p><p><strong>Take special care with Mododom:</strong></p><p>&bull; If you have kidney problems, follow your doctor&rsquo;s instructions carefully.</p><p>&bull; If you suffer from liver problems (liver function impairment or failure).</p><p>&bull; If you are also taking other medicines, please also read &ldquo;Taking other medicines&rdquo; section.</p><p>Domperidone may be associated with an increased risk of heart rhythm disorder and&nbsp; cardiac arrest. This risk may be more likely in those over 60 years old or in those taking&nbsp; doses higher than 30 mg per day. Domperidone should be used at the lowest effective&nbsp; dose in adults and children.</p><p>While taking <strong>Mododom</strong>, contact your doctor if you experience heart rhythm disorders such as palpitations, trouble breathing, loss of consciousness. Treatment with <strong>Mododom</strong> should be stopped.</p><p><strong>Duration of use:</strong></p><p>Do not take <strong>Mododom</strong> for longer than&nbsp; one week unless prescribed by your doctor.</p><p><strong>Taking other medicines:</strong></p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription or herbal medicines. Some other medicines may influence the use of <strong>Mododom</strong> or vice versa.</p><p>Do not take <strong>Mododom</strong> if you are taking oral ketoconazole (a medicine for fungal infections),&nbsp; or oral erythromycin (an antibiotic) or certain medicines that slow the metabolism&nbsp; (the breaking down) of other medicines in the body and can also affect your heart rhythm.</p><p>Tell your doctor or pharmacist if you are taking drugs to treat infection, heart problems&nbsp; or AIDS/HIV, the antidepressant nefazadone, or aprepitant, a medicine used to reduce&nbsp; nausea associated with cancer chemotherapy.</p><p><strong>Do not take Mododom if you are taking medicine to treat: </strong></p><p>&bull; Fungal infections such as azole anti-fungals, specifically oral ketoconazole, fluconazole or voriconazole.</p><p>&bull; Bacterial infections, specifically erythromycin, clarithromycin, telithromycin, moxifloxacin, pentamidine (these are antibiotics)</p><p>&bull; Heart problems or high blood pressure (e.g., amiodarone, dronedarone, quinidine, disopyramide, dofetilide, sotalol, diltiazem, verapamil)</p><p>&bull; Psychoses (e.g., haloperidol, pimozide, sertindole)</p><p>&bull; Depression (e.g., citalopram, escitalopram)</p><p>&bull; Gastro-intestinal disorders (e.g., cisapride, dolasetron, prucalopride)</p><p>&bull; Allergy (e.g., mequitazine, mizolastine)</p><p>&bull; Malaria (in particular halofantrine)</p><p>&bull; AIDS/HIV (protease inhibitors)</p><p>&bull; Cancer (e.g., toremifene, vandetanib, vincamine)</p><p><strong>Pregnant or Breast-feeding</strong></p><p>&bull; Do not take if you are pregnant or think you might be pregnant.</p><p>&bull; Do not take this medicine if you are breast-feeding unless your doctoror another health care professional has told you to.</p><p>&bull; Small amounts of domperidone have been detected in breast-milk. domperidone may cause unwanted side effects affecting the heart in a breast-fed baby. <strong>Mododom</strong> should be used during breast feeding only if your physician considers this clearly necessary. Ask your doctor for advice before taking this medicine.</p><p><strong>Some of the ingredients can cause problems</strong></p><p><strong>Mododom </strong>oral suspension contains sorbitol and sacharrin.</p><p>If you have been told by your doctor that you have an intolerance to some sugars contact your doctor before taking this medicinal product.</p><p><strong>Driving and using machinery</strong></p><p>This product should not be used to treat travel sickness.</p><p>Speak to your doctor or pharmacist about suitable treatments.</p><p>Domperidone does not affect your ability to drive or use machines.</p><p><strong>Taking Mododom with food and drink</strong></p><p>It is recommended to take <strong>Mododom </strong>before meals, as when taken after meals, the absorption of the medicine is slightly delayed.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take <strong>Mododom</strong><strong> </strong>exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist.</p><p>It is recommended to take <strong>Mododom</strong> before meals. If taken after meals, absorption of the drug is somewhat delayed.</p><p><strong>Mododom </strong>oral suspension comes with a measuring cup that can be used to measure the required dose.<strong> </strong></p><p><strong><u>Adults and adolescents (over 12 years and weighing 35 kg or more)</u></strong></p><p>The recommended duration of treatment is 7 days (one week).</p><p>The recommended dose is 10mg (10mL) up to three times daily with a maximum oral daily dose of 30mg.</p><p>Take your medicine using the plastic measuring cup provided with <strong>Mododom </strong>Oral Suspension. This cup is marked in ml (millilitres) to help you measure out the correct amount of this medicine.</p><p><strong><u>Infants and children</u></strong></p><p>0.25 mg/kg up to three times per day by mouth with a maximum daily dose of 0.75mg/kg.</p><p>You should not take <strong>Mododom</strong> for more than one week without consulting your doctor.</p><p>Your doctor may advise you to take your medicine in a different way, so you should always follow your doctor&rsquo;s advice about how and when to take your medicine and always read the patient information leaflet. If you feel that the effect of <strong>Mododom</strong> is too strong or too weak, talk to your doctor or pharmacist.</p><p>Should be given <strong>Mododom </strong>Oral Suspension using a suitably graduated oral measuring device. If you are not supplied with it please speak to your doctor or pharmacist.</p><p>Take your medicine 15 to 30 minutes before a meal.</p><p>Do not give more than 3 times in a 24 hour time period.</p><p>If you feel that the effect of <strong>Mododom</strong> is too strong or too weak, talk to your doctor or pharmacist.</p><p><strong>People with kidney problems </strong></p><p>Your doctor may tell you to take a lower dose or to take the medicine less often.</p><p><strong><u>If anyone takes too much</u></strong></p><p>If anyone takes too many <strong>Mododom</strong>, contact a doctor or your nearest Accident and Emergency department (Casualty) taking this leaflet and pack with you.</p><p>In the event of overdose, symptomatic treatment could be implemented. An ECG monitoring could be undertaken, because of the possibility of a heart problem called prolonged QT interval.</p><p>The signs of taking more than you should include feeling sleepy, confused, uncontrolled movements (especially in children) which include unusual eye movements, unusual movements of the tongue or abnormal posture (such as a twisted neck).</p><p><strong><u>If you forget to take the medicine</u></strong></p><p>You should only take this medicine as required following the dosage instructions above carefully. If you forget to take a dose, take the next dose when needed as long as you do not take more than 30mL in any 24 hour period. Do not take a double dose.</p><p><strong>If you have any further questions on the use of this medicaine, ask your doctor or pharmacist.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Website</strong>: www.sfda.gov.sa/npc Like all medicines, <strong>Mododom</strong> can cause side effects although not everybody gets them.</p><p><strong>Stop taking Mododom and see your doctor or go to a hospital straightaway if:</strong></p><p>&bull; You get swelling of the hands, feet, ankles, face, lips or throat which may cause difficulty in swallowing or breathing. You could also notice an itchy, lumpy rash (hives) or nettle rash (urticaria). This may mean you are having an allergic reaction to <strong>Mododom</strong>.</p><p>&bull; You notice any uncontrolled movements. These include irregular eye movements, unusual movements of the tongue, and abnormal posture such as a twisted neck, trembling and muscle stiffness. This is more likely to happen in children. These symptoms should stop once you stop taking <strong>Mododom</strong>.</p><p>&bull; You have a very fast or unusual heartbeat. This could be a sign of a life-threatening heart problem.</p><p>&bull; You have a fit (seizure)</p><p><strong>Other unwanted effects that have been observed with domperidone are listed below:</strong></p><p><strong>Common:</strong></p><p>&bull; Dry mouth.</p><p><strong>Uncommon: </strong></p><p>&bull; Anxiety.</p><p>&bull; Loss of interest in sex or diminished interest in sex.</p><p>&bull; Sleepiness</p><p>&bull; headache.</p><p>&bull; Diarrhoea.</p><p>&bull; Rash</p><p>&bull; Itchiness</p><p>&bull; Painful or tender breasts</p><p>&bull; Milk discharge from breasts</p><p>&bull; A general feeling of weakness.</p><p><strong>Not Known </strong></p><p>&bull; Stopped menstrual periods in women</p><p>&bull; Hives</p><p>&bull; Agitation</p><p>&bull; Nervousness</p><p>&bull; Inability to urinate</p><p>&bull; Changes in certain laboratory test results</p><p>&bull; Abnormal eye movements</p><p>&bull; Breast enlargement in men</p><p>Domperidone may be associated with an increased risk of heart rhythm disorder and cardiac arrest. This risk may be more likely in those over 60 years old or taking doses higher than 30 mg per day. An increase in the risk of serious ventricular arrhythmias and sudden cardiac death has been reported in some epidemiology studies. Due to the limitations of these data, risk factors and the exact frequency of these adverse reactions could not be defined.</p><p>Domperidone should be used at the lowest effective dose in adults and children.</p><p>Side effects such as feeling drowsy, nervous, agitated or irritable or having a fit are more likely to happen in children.</p><p><strong>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</strong></p><p><strong><u>&nbsp;</u></strong></p><p><strong><u>To report any side effect(s)</u></strong><strong><u>: </u></strong></p><p><strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p><strong>Fax</strong>: +966-11-205-7662</p><p><strong>Call NPC</strong> <strong>at </strong>+966-11-2038222,</p><p><strong>Exts</strong>: 2317-2356-2353-2354-2334-2340.</p><p><strong>Toll free phone</strong>: 8002490000</p><p><strong>E-mail</strong>: npc.drug@sfda.gov.sa</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp; Keep out of the reach and sight of children.</p><p>-&nbsp; Do not take <strong>Mododom</strong> after the expiry date which is stated on the carton and on the inner label.</p><p>-&nbsp; Store below 30&deg;C. Use the suspension within one month after opening.</p><p>-&nbsp; Do not take <strong>Mododom</strong> if you notice any visible sign of deterioration.</p><p>-&nbsp; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Each 1 mL of the suspension contains:</p><p><em>Active ingredient</em>:&nbsp;&nbsp; &nbsp;Domperidone &nbsp;1mg.</p><p><em>Other ingredients</em>: Sorbitol, avicel, sodium citrate, methylparaben, sodium saccharin, citric acid monohydrate, propylparaben, passion fruit flavour, tween 20 and purified water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Mododom oral suspension is available in packs containing 1 bottle (200mL) each.With measuring cup.



            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gulf Pharmaceutical Industries &quot; Julphar&quot;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                21/01/2016
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">إن <strong>مودودوم</strong> دواء مضاد للقيء، يعمل على منع الشعور بالغثيان. يحتوي <strong>مودودوم</strong> على المادة الفعالة دومبيريدون.</p><p dir="RTL">يستعمل <strong>مودودوم</strong> في تخفيف أعراض الغثيان والقيء لدى المرضى البالغين والأطفال.</p><p dir="RTL"><strong>يستعمل هذا الدواء فقط للعلاج على المدى القصير.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب عدم تناول هذا الدواء</strong><strong> </strong><strong>في الحالات التالية:</strong></p><p dir="RTL">&bull;&nbsp; إذا كنت تعاني من الحساسية (فرط الحساسية) تجاه دومبيريدون أو تجاه أياً من المكونات الغير فعالة الأخرى. تتضمن علامات التفاعلات التحسسية على: طفح جلدي، مشكلات في البلع أو في التنفس، تورم الشفتين، الوجه، الحلق أو اللسان.</p><p dir="RTL">&bull;&nbsp; إذا كنت تعاني من وجود مرض في الغدة النخامية (ورم برولاكتيني)</p><p dir="RTL">&bull;&nbsp; إذا عانيت مسبقاً من مشكلات في القلب بما في ذلك قصور في وظائف القلب، نوبة قلبية سابقة، ذبحة صدرية (آلام الصدر)، أو اضطراب نظم ضربات القلب بما في ذلك تسارع أو تباطؤ أو عدم انتظام ضربات القلب، دون استشارة طبيبك المعالج أولاً.</p><p dir="RTL">&bull;&nbsp; إذا كنت تعاني من وجود مرض كامن يؤثر على الجهاز الهضمي، على سبيل المثال:</p><p dir="RTL">-&nbsp; قرحة المعدة أو الإثنى عشر.</p><p dir="RTL">-&nbsp; انسداد الأمعاء أو انثقابها.</p><p dir="RTL">-&nbsp; اسوداد لون البراز في بعض الأحيان. قد يكون ذلك الأمر علامة على حدوث نزيف في المعدة أو الأمعاء.</p><p dir="RTL">-&nbsp; تعاني في كثير من الأحيان من تقلصات حادة في المعدة.</p><p dir="RTL">&bull;&nbsp; إذا كنت تعاني من مشاكل في الكبد.</p><p dir="RTL">&bull;&nbsp; إذا كنت تعاني من مشاكل تتسبب في انخفاض مستوى كلاً من البوتاسيوم أو المغنيسيوم أو ارتفاع مستوى البوتاسيوم في الدم.</p><p dir="RTL">&bull;&nbsp; إذا كنت تتناول أدوية معينة التي تبطئ عملية التمثيل الغذائي (الأيض) للأدوية الأخرى في الجسم، والتي قد تؤثر أيضاً على نظم ضربات القلب على سبيل المثال كيتوكونازول، فلوكونازول، أو فوريكونازول، والتي تستعمل لعلاج الالتهابات الفطرية، والمضادات الحيوية على سبيل المثال الاريثروميسين، كلاريثروميسين أو تيليثروميسين. أو الأميودارون، وهو دواء القلب.</p><p dir="RTL"><strong>يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه للحصول على النصحية </strong><strong>دون أن تتناول</strong><strong> مودودوم،</strong><strong> </strong><strong>إذا كان أياً مما سبق ينطبق عليك.</strong></p><p dir="RTL"><strong>رعاية خاصة قبل تناول مودودوم:</strong></p><p dir="RTL">&bull;&nbsp; إذا كنت تعاني من مشكلات في الكلى يجب عليك اتباع تعليمات طبيبك المعالج بدقة</p><p dir="RTL">&bull;&nbsp; إذا كنت تعاني من مشكلات في الكبد (خلل أو فشل في وظائف الكبد)</p><p dir="RTL">&bull;&nbsp; إذا كنت تتناول أية أدوية أخرى، يرجى منك أيضاً قراءة فقرة &quot; تناول الأدوية الأخرى&quot;</p><p dir="RTL">قد يصاحب تناول دومبيريدون زيادة حدوث مخاطر اضطراب نظم ضربات القلب والسكته القلبية. كما قد يكون المرضى بعمر أكبر من 60 سنة أو الذين يتناولون جرعات أعلى من 30 ملغم يومياً أكثر عرضة لحدوث هذه المخاطر.</p><p dir="RTL">ينبغي استعمال دومبيريدون بأقل جرعة فعالة في البالغين والأطفال.</p><p dir="RTL">يرجى منك التواصل مع طبيبك المعالج وكما يجب إيقاف العلاج باستعمال <strong>مودودوم</strong>، في حال تعرضك لاضطرابات في نظم القلب على سبيل المثال خفقان، صعوبة في التنفس، وفقدان الوعي أثناء تناول <strong>مودودوم</strong>.</p><p dir="RTL"><strong>مدة الاستعمال:</strong></p><p dir="RTL">يجب عدم استعمال <strong>مودودوم</strong> لفترة أكثر من أسبوع واحد ما لم يصف الطبيب خلاف ذلك.</p><p dir="RTL"><strong>تناول الأدوية الأخرى:</strong></p><p dir="RTL">يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت تتناول أو تناولت مؤخراً أية أدوية أخرى، بما في ذلك الأدوية التي تصرف بدون وصفة طبية أو الأدوية العشبية. قد تؤثر بعض الأدوية الأخرى على آلية عمل <strong>مودودوم</strong> أو قد<strong> </strong>يؤثر <strong>مودودوم</strong> على آلية عمل بعض الأدوية الأخرى.</p><p dir="RTL">يجب عدم تناول <strong>مودودوم</strong> إذا كنت تتناول الكيتوكونازول عن طريق الفم (دواء للالتهابات الفطرية)، أو الاريثروميسين عن طريق الفم (مضاد حيوي) أو الأدوية معينة التي تبطئ عملية التمثيل الغذائي (الأيض) للأدوية الأخرى في الجسم، والتي قد تؤثر أيضاً على نظم ضربات القلب .</p><p dir="RTL">يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت تتناول أدوية أخرى لعلاج حالات العدوى، مشاكل في القلب أو لعلاج الإيدز / فيروس نقص المناعة البشرية المكتسبة، ومضاد الاكتئاب نيفازادون، أو أبريبيتانت، وهو دواء يستعمل للحد من الغثيان المصاحب للعلاج الكيميائي للسرطان.</p><p dir="RTL"><strong>يجب عليك عدم تناول مودودوم إذا كنت تتناول أياً من الأدوية التي تستعمل لعلاج الحالات الصحية التالية:</strong></p><p dir="RTL">&bull;&nbsp; العدوى الفطرية على سبيل المثال مضادات الفطريات من مجموعة الأزول وبصورة خاصة التي يتم تناولها عن طريق الفم كيتوكونازول، فلوكونازول أو فوريكونازول.</p><p dir="RTL">&bull;&nbsp; العدوى البكتيرية، بصورة خاصة الإريثروميسين، كلاريثروميسين، تيليثروميسين، موكسيفلوكساسين، بينتاميدين (مضادات حيوية).</p><p dir="RTL">&bull;&nbsp; المشكلات القلبية أو ارتفاع ضغط الدم (على سبيل المثال الأميودارون، درونيدارون، كوينيدين، دايزوبيراميد، دوفيتيليد، &nbsp;سوتالول، ديلتيازيم، فيراباميل)</p><p dir="RTL">&bull;&nbsp; الذهان (على سبيل المثال، هالوبيريدول، بيموزيد، السرتيندول)</p><p dir="RTL">&bull;&nbsp; الاكتئاب (على سبيل المثال، سيتالوبرام، إسيتالوبرام)</p><p dir="RTL">&bull;&nbsp; الاضطرابات المعدية المعوية (على سبيل المثال، سيسابريد، دولاسيترون، بروكالوبريد)</p><p dir="RTL">&bull;&nbsp; الحساسية (على سبيل المثال، ميكويتازين، ميزولاستين)</p><p dir="RTL">&bull;&nbsp; الملاريا (وبصورة خاصة هالوفانترين)</p><p dir="RTL">&bull;&nbsp; الإيدز / نقص المناعة البشرية المكتسبة (مثبطات الأنزيم البروتيني)</p><p dir="RTL">&bull;&nbsp; السرطان (على سبيل المثال، توريميفين، فانديتانيب، فينكامين)</p><p dir="RTL"><strong>الحمل أو الرضاعة الطبيعية</strong></p><p dir="RTL">&bull;&nbsp; يجب عدم تناول هذا الدواء إذا كنت حاملاً أو تعتقدين أنك قد تكونين حاملاً.</p><p dir="RTL">&bull;&nbsp; يجب عدم تناول هذا الدواء إذا كنت ترضعين طفلك رضاعة طبيعية ما لم يخبرك طبيبك المعالج أو أياً من ممارسي الرعاية الصحية بذلك.</p><p dir="RTL">&bull;&nbsp; تفرز كميات ضئيلة من دومبيريدون في حليب الثدي. قد يتسبب دومبيريدون في حدوث تأثيرات جانبية غير مرغوب فيها تؤثر على قلب الطفل الرضيع. يجب استعمال <strong>مودودوم</strong> أثناء الرضاعة الطبيعية فقط إذا رأى الطبيب المعالج ضرورة لذلك بصورة واضحة. يرجى منك استشارة طبيبك المعالج قبل تناول هذا الدواء.</p><p dir="RTL"><strong>معلومات هامة عن بعض مكونات مودودوم:</strong></p><p dir="RTL">يحتوي <strong>مودودوم</strong> معلق فموي على السوربيتول وسكارين.</p><p dir="RTL">يرجى منك استشارة طبيبك المعالج قبل تناول هذا الدواء إذا كان قد اخبرك مسبقاً بأنك تعاني من مشكلة تتمثل في عدم القدرة على تحمل بعض أنواع السكر.</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong><strong> </strong></p><p dir="RTL">يجب عدم استعمال هذا الدواء لعلاج حالات الغثيان المصاحبة للسفر.</p><p dir="RTL">يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه عن العلاجات الأخرى المناسبة التي يمكنك تناولها.</p><p dir="RTL">لا تؤثر مادة الدومبيريدون على قدرتك على القيادة أو استخدام الآلات.</p><p dir="RTL"><strong>تناول مودودوم مع الطعام والشراب</strong></p><p dir="RTL">يوصى بتناول <strong>مودودوم</strong> قبل وجبات الطعام، حيث يؤدي تناوله بعد الوجبات إلى تأخر امتصاص الدواء قليلاً.<strong> </strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب عليك دائماً تناول <strong>مودودوم</strong> بدقة وفقاً لتعليمات الطبيب المعالج. يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا لم تكن متأكداً من كيفية تناول هذا الدواء.</p><p dir="RTL">يوصى بتناول <strong>مودودوم</strong> قبل وجبات الطعام، حيث يؤدي تناوله بعد الوجبات، في بعض الأحيان إلى تأخر امتصاص الدواء قليلا.</p><p dir="RTL">إن <strong>مودودوم</strong> معلق فموي مزود بكوب المعايرة لاستعماله في قياس الجرعة المطلوبة.</p><p dir="RTL"><strong><u>البالغون والمراهقون (أكبر من 12سنة والذين يزنون 35 كلغم أو أكثر) </u></strong></p><p dir="RTL">الفترة الزمنية الموصى بها للعلاج هي 7 أيام (أسبوع واحد).</p><p dir="RTL">يبلغ مقدار الجرعة الموصى بها 10 ملغم (10 ملليلتر) يتم تناولها حتى ثلاث مرات يومياً، الحد الأقصى للجرعة اليومية<br />عن طريق الفم هي 30 ملغم.</p><p dir="RTL">تناول هذا الدواء باستعمال كوب المعايرة البلاستيكي الموجود مع <strong>مودودوم</strong> معلق فموي. إن هذا الكوب قد تم تدريجه بوضع علامات تشير إلى عدد الملليلترات وذلك لمساعدتك على قياس الجرعة الصحيحة من هذا الدواء.</p><p dir="RTL"><strong><u>الرضع والأطفال</u></strong></p><p dir="RTL">يبلغ مقدار الجرعة 0,25 ملغم/كلغم من وزن الجسم يتم تناولها عن طريق الفم حتى ثلاث مرات يومياً، الحد الأقصى للجرعة اليومية هي<br />0,75 ملغم/كلغم.</p><p dir="RTL">يجب عدم تناول <strong>مودودوم</strong> لأكثر من أسبوع واحد دون استشارة الطبيب المعالج.</p><p dir="RTL">قد ينصحك طبيبك المعالج بتناول الدواء بطريقة مختلفة، يجب عليك اتباع تعليمات طبيبك المعالج دائماً بدقة حول كيفية ووقت تناول هذا الدواء، كما يجب عليك دائما قراءة النشرة الدوائية الموجهة للمريض. يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه، إذا كنت تشعر بأن تأثير <strong>مودودوم</strong> قوي جداً أو ضعيف للغاية.</p><p dir="RTL">ينبغي إعطاء معلق <strong>مودودوم</strong> الفموي باستعمال أداة مدرجة لمعايرة الجرعة. إذا لم يتم تزويدك بمثل هذه الأداه يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه.</p><p dir="RTL">يتم تناول هذا الدواء قبل وجبات الطعام بحوالي 15 إلى 30 دقيقة.</p><p dir="RTL">لا تقم بإعطاء الدواء أكثر من 3 مرات خلال 24 ساعة.</p><p dir="RTL">في حال الشعور بأن تأثير <strong>مودودوم</strong> قوي للغاية أو ضعيف للغاية يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه.</p><p dir="RTL"><strong>المرضى الذين يعانون من مشكلات في الكلى</strong></p><p dir="RTL">قد يخبرك طبيبك المعالج بتناول أقل مقدار ممكن من الجرعة أو قد يقلل عدد مرات تناول الدواء.</p><p dir="RTL"><strong><u>إذا تناول أحد الأشخاص على سبيل الخطأ الكثير من الدواء </u></strong></p><p dir="RTL">إذا تناول أحد الأشخاص على سبيل الخطأ الكثير من <strong>مودودوم</strong>، يرجى منك التواصل مع طبيبك المعالج أو التوجه إلى اقرب قسم حوادث وطوارئ بالمستشفى حاملاً معك هذه النشرة الدوائية وعبوة الدواء.</p><p dir="RTL">في حالات فرط الجرعة ينبغي اللجوء إلى معالجة الأعراض، كما يجب إخضاع المريض لتخطيط القلب الكهربائي حيث أنه من المحتمل حدوث مشكلة في القلب وهي إطالة الزمن الفاصل بين موجات كيو تي في رسم مخطط كهربية القلب.</p><p dir="RTL">تتضمن علامات فرط الجرعة على الشعور بالنعاس، الارتباك، عدم التحكم في حركات الجسم (بصورة خاصة لدى الأطفال) والتي تتضمن حركة العين، واللسان بصورة غير معتادة أو حدوث وضعيات غير طبيعية (على سبيل المثال التواء الرقبة).<strong><u> </u></strong></p><p dir="RTL"><strong><u>إذا سهوت عن تناول هذا الدواء:</u></strong></p><p dir="RTL">يجب تناول هذا الدواء وفقاً لحاجتك وذلك باتباع تعليمات حول الجرعة المذكورة أعلاه بدقة.</p><p dir="RTL">إذا سهوت عن تناول إحدى الجرعات فتناول الجرعة التالية عند الحاجة طالما لم تتناول أكثر من 30 ملليلتر خلال<br />24 ساعة. يجب عليك عدم تناول جرعة مضاعفة.</p><p dir="RTL"><strong>يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه، إذا كان لديك أية أسئلة إضافية حول استعمال هذا الدواء.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو عليه الحال مع جميع الأدوية، قد يتسبب <strong>مودودوم</strong> في حدوث تأثيرات جانبية، بالرغم من ذلك فإنها قد لا تحدث لكل شخص.</p><p dir="RTL"><strong>يرجى منك التوقف عن تناول مودودوم والتوجه إلى طبيبك المعالج أو إلى المستشفى في الحالات التالية</strong><strong>:</strong></p><p dir="RTL">&bull;&nbsp; إذا تعرضت لتورم في اليدين، القدمين، الكاحلين، الوجه، الشفتين أو الحلق الأمر الذي قد يسبب صعوبة في البلع أو التنفس.</p><p dir="RTL">قد تلاحظ أيضاً حدوث حكة، طفح جلدي على شكل خلايا النحل، أو طفح القراص (شرى). الأمر الذي يشير إلى أنك تعاني من تفاعلات تحسسية تجاه <strong>مودودوم</strong>.</p><p dir="RTL">&bull;&nbsp; إذا لاحظت حدوث حركات لا إرادية والتي تتضمن حركات غير منتظمة في العين، حركات غير معتادة في اللسان وحدوث وضعيات غير طبيعية مثل التواء الرقبة، ارتعاش وتصلب العضلات. يرجح حدوث ذلك غالبا ً لدى الأطفال. يجب أن تتوقف هذه الأعراض بمجرد توقفك عن تناول<strong> مودودوم</strong>.</p><p dir="RTL">&bull;&nbsp; إذا عانيت من تسارع شديد في ضربات القلب أو أصبحت ضربات القلب غير طبيعية. قد يكون هذا الأمر علامة على وجود مشكلة في القلب تهدد الحياة.</p><p dir="RTL">&bull;&nbsp; إذا كنت تعاني من نوبات تشنجية.</p><p dir="RTL"><strong>كما لوحظ حدوث تأثيرات جانبية أخرى غير مرغوب فيها مع دومبيريدون ذكرت أدناه:</strong></p><p dir="RTL"><strong>شائعة:</strong></p><p dir="RTL">&bull;&nbsp; جفاف الفم</p><p dir="RTL"><strong>غير شائعة:</strong></p><p dir="RTL">&bull;&nbsp; القلق</p><p dir="RTL">&bull;&nbsp; فقدان أو فتور في الرغبة الجنسية</p><p dir="RTL">&bull;&nbsp; النعاس</p><p dir="RTL">&bull;&nbsp; الصداع</p><p dir="RTL">&bull;&nbsp; إسهال</p><p dir="RTL">&bull;&nbsp; طفح جلدي</p><p dir="RTL">&bull;&nbsp; حكة</p><p dir="RTL">&bull;&nbsp; شعور بالألم عند لمس الثديين</p><p dir="RTL">&bull;&nbsp; خروج حليب من الثدي</p><p dir="RTL"><strong>&bull;&nbsp; </strong>شعور عام بالضعف</p><p dir="RTL"><strong>غير معروفة:</strong></p><p dir="RTL">&bull;&nbsp; توقف الدورة الشهرية لدى النساء</p><p dir="RTL">&bull;&nbsp; طفح جلدي على شكل خلايا النحل</p><p dir="RTL">&bull;&nbsp; الهياج</p><p dir="RTL">&bull;&nbsp; العصبية</p><p dir="RTL">&bull;&nbsp; عدم القدرة على التبول</p><p dir="RTL">&bull;&nbsp; حدوث تغييرات في بعض نتائج الفحوصات المخبرية</p><p dir="RTL"><strong>&bull;&nbsp; </strong>حركات غير طبيعية في العين</p><p dir="RTL"><strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp; </strong>تضخم الثدي لدى الرجال</p><p dir="RTL">قد يصاحب تناول دومبيريدون زيادة حدوث مخاطر اضطراب نظم ضربات القلب والسكته القلبية. كما قد يكون المرضى بعمر أكبر من 60 سنة أو الذين يتناولون جرعات أعلى من 30 ملغم يومياً أكثر عرضة لحدوث هذه المخاطر.</p><p dir="RTL">تم تسجيل زيادة مخاطر حدوث الرجفان البطيني والموت القلبي المفاجئ في بعض الدراسات الوبائية ونظراً لكون هذه البيانات محدودة، فإنه لم يتمكن حتى الآن من معرفة عوامل الخطر ومعدل تكرار حدوثها بصورة دقيقة.</p><p dir="RTL">ينبغي استعمال دومبيريدون بأقل جرعة فعالة في البالغين والأطفال.</p><p dir="RTL">إن التأثيرات الجانبية على سبيل المثال الشعور بالنعاس، العصبية، الهياج أو تعكر المزاج أو حدوث التشنجات تعد أكثر حدوثاً لدى الأطفال.</p><p dir="RTL"><strong>يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه، في حال زيادة حدة أياً من التأثيرات الجانبية، أو لاحظت أية تأثيرات جانبية ولم تذكر في هذه النشرة.</strong></p><p dir="RTL"><strong><u>&nbsp;</u></strong></p><p dir="RTL"><strong><u>للإبلاغ عن حدوث أية تأثيرات جانبية:</u></strong><br /><strong>المركز الوطني للتيقظ والسلامة الدوائية</strong></p><p dir="RTL"><strong>رقم الفاكس: </strong>7662-205-11-966+</p><p dir="RTL"><strong>يرجى الاتصال بالمركز الوطني للتيقظ والسلامة الدوائية على: </strong>2038222-11-966+<strong>&nbsp;<br />وصلة هاتف:</strong>2340-2334-2354-2353-2356-2317</p><p dir="RTL"><strong>الهاتف المجاني: </strong>8002490000</p><p dir="RTL"><strong>البريد الإلكتروني:</strong><strong> </strong><strong>&nbsp;</strong>npc.drug@sfda.gov.sa</p><p dir="RTL"><strong>الموقع الإلكتروني: </strong>www.sfda.gov.sa/npc</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; يحفظ بعيداً عن متناول ومرأى الأطفال.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; يجب عدم تناول <strong>مودودوم</strong> بعد تاريخ انتهاء الصلاحية المذكور على العبوة والملصق الداخلي للزجاجة.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; يحفظ في درجة حرارة &nbsp;أقل من 30&ordm;م. استخدم المعلق خلال شهر واحد بعد فتح العبوة.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; يجب عدم تناول <strong>مودودوم</strong> إذا لاحظت وجود علامات تلف واضحة.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; يجب عدم التخلص من الأدوية عبر المياه المبتذلة (مياه الصرف الصحي) أو النفايات المنزلية. اسأل الصيدلي الذي تتعامل معه عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحتوي كل 1 ملليلتر من المعلق على:</p><p dir="RTL">المادة الفعالة:&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;دومبيريدون&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1 ملغم.</p><p dir="RTL">المواد غير الفعالة: &nbsp;السوربيتول، أفيسيل، سترات الصوديوم، ميثيل الباربين، سكارين الصوديوم، حمض الستريك أحادي الهيدرات، بروبيل الباربين، نكهة فواكه، تويين 20 وماء منقى.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يتوفر معلق <strong>مودودوم</strong> الفموي في عبوات تحتوي كلاً منها على زجاجة واحدة (سعة 200 ملليلتر). مع كوب معايرة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>&quot;الخليج للصناعات الدوائية&quot; جلفار</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            21-01-2016
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Mododom 5mg/5mL Suspension
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each teaspoonful (5mL) contains:
Item No.	Material Name	Scale (mg/5mL)
		
	Active Ingredient:	
1.		Domperidone 	5.000
		
	Inactive Ingredients:	
1.		Sorbitol 70% solution	2000.000
2.		Sodium saccharin 	7.500
3.		Avicel RC 	70.000
4.		Methylparaben 	9.000
5.		Propylparaben 	1.000
6.		Citric acid monohydrate 	1.500
7.		Sodium citrate 	15.000
8.		Tween 20 (polysorbate 20)	0.500
9.		Passion fruit flavour 	1.000
10.		Purified water	q.s. to 5mL

For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Suspension
Description: Creamy white, homogenous suspension having fruit flavour and palatable taste

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Mododom </strong>is indicated for the relief of the symptoms of nausea and vomiting.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Mododom </strong>should be used at the lowest effective dose for the shortest duration necessary to control nausea and vomiting.</p><p>It is recommended to take <strong>Mododom</strong> before meals. If taken after meals, absorption of the drug is somewhat delayed.</p><p>Patients should try to take each dose at the scheduled time. If a scheduled dose is missed, the missed dose should be omitted and the usual dosing schedule resumed. The dose should not be doubled to make up for a missed dose.</p><p>Usually, the maximum treatment duration should not exceed one week.</p><p>See section 4.4. for further information.</p><p><strong><em>Adults and adolescents (12 years of age and older and weighing 35 kg or more)</em></strong></p><p>10 mg up to three times per day with a maximum dose of 30 mg per day</p><p><strong><em>Children (less than 12 years of age) body weight up to 35 kg</em></strong></p><p>250 mcg/kg up to 3 times daily; maximum dose is 750 mcg/kg daily</p><p><strong><em><u>Hepatic Impairment</u></em></strong></p><p>Domperidone is contraindicated in moderate or severe hepatic impairment (see section 4.3). Dose modification in mild hepatic impairment is however not needed (see section 5.2).</p><p><strong><em><u>Renal Impairment</u></em></strong></p><p>Since the elimination half-life of domperidone is prolonged in severe renal impairment, on repeated administration, the dosing frequency of domperidone should be reduced to once or twice daily depending on the severity of the impairment, and the dose may need to be reduced. Such patients on prolonged therapy should be reviewed regularly (see sections 4.4 and 5.2)</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Mododom is contraindicated in the following situations:
	Known hypersensitivity to domperidone or any of the excipients
	Prolactin-releasing pituitary tumour (prolactinoma).
	when stimulation of the gastric motility could be harmful e.g in patients with gastro-intestinal haemorrhage, mechanical obstruction or perforation.
	in patients with moderate or severe hepatic impairment (see section 5.2).
	in patients who have known existing prolongation of cardiac conduction intervals, particularly QTc, patients with significant electrolyte disturbances or underlying cardiac diseases such as congestive heart failure (see section 4.4)
	co-administration with QT-prolonging drugs (see section 4.5)
	co-administration with potent CYP3A4 inhibitors (regardless of their QT prolonging effects) (see section 4.5)

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Cardiovascular effects</u></strong></p><p>Domperidone has been associated with prolongation of the QT interval on the electrocardiogram. During post-marketing surveillance, there have been very rare cases of QT prolongation and torsades de pointes in patients taking domperidone. These reports included patients with confounding risk factors, electrolyte abnormalities and concomitant treatment which may have been contributing factors (see section 4.8).</p><p>Epidemiological studies showed that domperidone was associated with an increased risk of serious ventricular arrhythmias or sudden cardiac death (see section 4.8). A higher risk was observed in patients older than 60 years, patients taking daily doses greater than 30 mg, and patients concurrently taking QT-prolonging drugs or CYP3A4 inhibitors.</p><p>Domperidone should be used at the lowest effective dose in adults and children.</p><p>Domperidone is contraindicated in patients with known existing prolongation of cardiac conduction intervals, particularly QTc, in patients with significant electrolyte disturbances (hypokalaemia, hyperkalaemia, hypomagnesaemia), or bradycardia, or in patients with underlying cardiac diseases such as congestive heart failure due to increased risk of ventricular arrhythmia (see section 4.3.). Electrolyte disturbances (hypokalaemia, hyperkalaemia, hypomagnesaemia) or bradycardia are known to be conditions increasing the proarrythmic risk.</p><p>Treatment with domperidone should be stopped if signs or symptoms occur that may be associated with cardiac arrhythmia, and the patients should consult their physician.</p><p>Patients should be advised to promptly report any cardiac symptoms.</p><p><strong><u>Use in infants</u></strong></p><p>Although neurological side effects are rare (see section 4.8), the risk of neurological side effects is higher in young children since metabolic functions and the blood-brain barrier are not fully developed in the first months of life. Overdosing may cause extrapyramidal symptoms in children, but other causes should be taken into consideration.</p><p><strong><u>Renal impairment</u></strong></p><p>The elimination half-life of domperidone is prolonged in severe renal impairment. For repeated administration, the dosing frequency of domperidone should be reduced to once or twice daily depending on the severity of the impairment. The dose may also need to be reduced.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The main metabolic pathway of domperidone is through CYP3A4.&nbsp;<em>In vitro</em>&nbsp;data suggest that the concomitant use of drugs that significantly inhibit this enzyme may result in increased plasma levels of domperidone.</p><p>Increased risk of occurrence of QT-interval prolongation, due to pharmacodynamic and/or pharmacokinetic interactions.</p><p><strong><u>Concomitant use of the following substances is contraindicated</u></strong></p><p>QTc prolonging medicinal products</p><ul><li>anti-arrhythmics class IA (e.g., disopyramide, hydroquinidine, quinidine)</li><li>anti-arrhythmics class III (e.g., amiodarone, dofetilide, dronedarone, ibutilide, sotalol)</li><li>certain anti-psychotics (e.g., haloperidol, pimozide, sertindole)</li><li>certain anti-depressants (e.g., citalopram, escitalopram)</li><li>certain antibiotics (e.g. , erythromycin, levofloxacin, moxifloxacin, spiramycin)</li><li>certain antifungal agents (e.g., pentamidine)</li><li>certain antimalarial agents (in particular halofantrine, lumefantrine)</li><li>certain gastro-intestinal medicines (e.g., cisapride, dolasetron, prucalopride)</li><li>certain antihistaminics (e.g., mequitazine, mizolastine)</li><li>certain medicines used in cancer (e.g., toremifene, vandetanib, vincamine)</li><li>certain other medicines (e.g., bepridil, diphemanil, methadone) (see section 4.3).</li></ul><p>Potent CYP3A4 inhibitors (<u>regardless of their QT prolonging effects</u>), i.e.:</p><ul><li>protease inhibitors</li><li>systemic azole antifungals</li><li>some macrolides (erythromycin, clarithromycin, telithromycin) (see section 4.3).</li></ul><p><strong><u>Concomitant use of the following substances is not recommended</u></strong></p><p>Moderate CYP3A4 inhibitors i.e. diltiazem, verapamil and some macrolides. (see section 4.3)</p><p><strong><u>Concomitant use of the following substances requires caution in use</u></strong></p><p>Caution with bradycardia and hypokalaemia-inducing drugs, as well as with the following macrolides involved in QT-interval prolongation: azithromycin and roxithromycin (clarithromycin is contra-indicated as it is a potent CYP3A4 inhibitor).</p><p>The above list of substances is representative and not exhaustive.</p><p>Separate&nbsp;<em>in vivo pharmacokinetic/pharmacodynamic&nbsp;</em>interaction studies with oral ketoconazole or oral erythromycin in healthy subjects confirmed a marked inhibition of domperidone&#39;s CYP3A4 mediated first pass metabolism by these drugs.</p><p>With the combination of oral domperidone 10mg four times daily and ketoconazole 200mg twice daily, a mean QTc prolongation of 9.8 msec was seen over the observation period, with changes at individual time points ranging from 1.2 to 17.5 msec. With the combination of domperidone 10mg four times daily and oral erythromycin 500mg three times daily, mean QTc over the observation period was prolonged by 9.9 msec, with changes at individual time points ranging from 1.6 to 14.3 msec. Both the Cmax and AUC of domperidone at steady state were increased approximately three-fold in each of these interaction studies. In these studies domperidone monotherapy at 10mg given orally four times daily resulted in increases in mean QTc of 1.6 msec (ketoconazole study) and 2.5 msec (erythromycin study), while ketoconazole monotherapy (200mg twice daily) led to increases in QTc of 3.8 and 4.9 msec, respectively, over the observation period.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Pregnancy</u></strong></p><p>There are limited post-marketing data on the use of domperidone in pregnant women. Studies in animals have shown reproductive toxicity at maternally toxic doses (see section 5.3). Domperidone should only be used during pregnancy when justified by the anticipated therapeutic benefit.</p><p><strong><u>Breast-feeding</u></strong></p><p>Domperidone is excreted in human milk and breast-fed infants receive less than 0.1 % of the maternal weight-adjusted dose. Occurrence of adverse effects, in particular cardiac effects cannot be excluded after exposure via breast milk. A decision should be made whether to discontinue breast-feeding or to discontinue/abstain from domperidone therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman. Caution should be exercised in case of QTc prolongation risk factors in breast-fed infants.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Domperidone has no or negligible influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Tabulated list of adverse reactions</u></strong></p><p>The safety of domperidone was evaluated in clinical trials and in postmarketing experience. The clinical trials included 1275 patients with dyspepsia, gastro-oesophageal reflux disorder (GORD), Irritable Bowel Syndrome (IBS), nausea and vomiting or other related conditions in 31 double-blind, placebo-controlled studies. All patients were at least 15 years old and received at least one dose of domperidone base. The median total daily dose was 30 mg (range 10 to 80 mg), and median duration of exposure was 28 days (range 1 to 28 days). Studies in diabetic gastroparesis or symptoms secondary to chemotherapy or parkinsonism were excluded.</p><p>The following terms and frequencies are applied:</p><p>very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &lt;1/100); rare (&ge;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000), Where frequency cannot be estimated from clinical trials data, it is recorded as &ldquo;Not known&rdquo;.</p><table border="1" cellspacing="0" cellpadding="0" style="width:566px"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td colspan="3" style="vertical-align:top"><p><strong>Adverse Drug Reaction</strong></p><p><strong>Frequency</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>Common</strong></p></td><td style="vertical-align:top"><p><strong>Uncommon</strong></p></td><td style="vertical-align:top"><p><strong>Not known</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Anaphylactic reaction (including anaphylactic shock)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Psychiatric disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Loss of libido</p><p>Anxiety</p></td><td style="vertical-align:top"><p>Agitation</p><p>Nervousness</p></td></tr><tr><td style="vertical-align:top"><p><strong>Nervous system disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Somnolence</p><p>Headache</p></td><td style="vertical-align:top"><p>Convulsion</p><p>Extrapyramidal disorder</p></td></tr><tr><td style="vertical-align:top"><p><strong>Eye disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Oculogyric crisis</p></td></tr><tr><td style="vertical-align:top"><p><strong>Cardiac disorders (see section 4.4)</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Ventricular arrhythmias</p><p>Sudden cardiac death</p><p>QTc prolongation</p><p>Torsade de Pointes</p></td></tr><tr><td style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td><td style="vertical-align:top"><p>Dry mouth</p></td><td style="vertical-align:top"><p>Diarrhoea</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorder</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Rash</p><p>Pruritus</p></td><td style="vertical-align:top"><p>Urticaria</p><p>Angioedema</p></td></tr><tr><td style="vertical-align:top"><p><strong>Renal and urinary disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Urinary retention</p></td></tr><tr><td style="vertical-align:top"><p><strong>Reproductive system and breast disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Galactorrhoea</p><p>Breast pain</p><p>Breast tenderness</p></td><td style="vertical-align:top"><p>Gynaecomastia</p><p>Amenorrhoea</p></td></tr><tr><td style="vertical-align:top"><p><strong>General disorders and administration site conditions</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Asthenia</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Investigations</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Liver function test abnormal</p><p>Blood prolactin increased</p></td></tr></tbody></table><p>In 45 studies where domperidone was used at higher dosages, for longer duration and for additional indications including diabetic gastroparesis, the frequency of adverse events (apart from dry mouth) was considerably higher. This was particularly evident for pharmacologically predictable events related to increased prolactin. In addition to the reactions listed above, akathisia, breast discharge, breast enlargement, breast swelling, depression, hypersensitivity, lactation disorder, and irregular menstruation were also noted.</p><p><strong><u>Paediatric population</u></strong></p><p>Extrapyramidal disorder occurs primarily in neonates and infants</p><p>Other central nervous system-related effects of convulsionand agitation alsoare primarily reported in infants and children.</p><p><strong><em><u>&nbsp;</u></em></strong></p><p><strong><em><u>To report any side effect(s)</u></em></strong><strong><em><u>:</u></em></strong><strong><em><u> </u></em></strong></p><p><strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p><strong>Fax:</strong> +966-11-205-7662</p><p><strong>Call NPC at</strong> +966-11-2038222, <strong>Exts:</strong> 2317-2356-2353-2354-2334-2340.</p><p><strong>Toll free phone:</strong> 8002490000</p><p><strong>E-mail:</strong> npc.drug@sfda.gov.sa</p><p><strong>Website:</strong> www.sfda.gov.sa/npc</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em><u>Symptoms</u></em></strong></p><p>Overdose has been reported primarily in infants and children. Symptoms of overdosage may include agitation, altered consciousness, convulsions, disorientation, somnolence and extrapyramidal reactions.</p><p><strong><em><u>Treatment</u></em></strong></p><p>There is no specific antidote to domperidone, but in the event of overdose, standard symptomatic treatment should be given immediately. Gastric lavage as well as the administration of activated charcoal may be useful. ECG monitoring should be undertaken, because of the possibility of QT interval prolongation. Close medical supervision and supportive therapy is recommended.</p><p>Anticholinergic, anti-parkinson drugs may be helpful in controlling the extrapyramidal reactions.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group:</strong> Propulsives, ATC code: A03F A 03</p><p><strong><u>Mechanism of action</u></strong></p><p>Domperidone is a dopamine antagonist with anti-emetic properties, Domperidone does not readily cross the blood-brain barrier. In domperidone users, especially in adults, extrapyramidal side effects are very rare, but domperidone promotes the release of prolactin from the pituitary. Its anti-emetic effect may be due to a combination of peripheral (gastrokinetic) effects and antagonism of dopamine receptors in the chemoreceptor trigger zone, which lies outside the blood-brain barrier in the area postrema. Animal studies, together with the low concentrations found in the brain, indicate a predominantly peripheral effect of domperidone on dopamine receptors.</p><p>Studies in man have shown oral domperidone to increase lower oesophaegeal pressure, improve antroduodenal motility and accelerate gastric emptying. There is no effect on gastric secretion.</p><p>In accordance with ICH&mdash;E14 guidelines, a thorough QT study was performed. This study included a placebo, an active comparator and a positive control and was conducted in healthy subjects with up to 80 mg per day 10 or 20 mg administered 4 times a day of domperidone. This study found a maximal difference of QTc between domperidone and placebo in LS-means in the change from baseline of 3.4 msec for 20 mg domperidone administered 4 times a day on Day 4. The 2-sided 90 % CI (1.0 to 5.9 msec) did not exceed 10 msec. No clinically relevant QTc effects were observed in this study when domperidone was administered at up to 80 mg/day (i.e., more than twice the maximum recommended dosing).</p><p>However, two previous drug-drug interaction studies showed some evidence of QTc prolongation when domperidone was administered as monotherapy (10 mg 4 times a day).The largest time-matched mean difference of QTcF between domperidone and placebo was 5.4 msec (95 % CI: -1.7 to 12.4) and 7.5 msec (95 % CI: 0.6 to 14.4), respectively.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Absorption</u></strong></p><p>Domperidone is rapidly absorbed after oral administration, with peak plasma concentrations occurring at approximately 1hr after dosing. The Cmax and AUC values of domperidone increased proportionally with dose in the 10 mg to 20 mg dose range. A 2- to 3-fold accumulation of domperidone AUC was observed with repeated four times daily (every 5 hr) dosing of domperidone for 4 days.</p><p>The low absolute bioavailability of oral domperidone (approximately 15%) is due to an extensive first-pass metabolism in the gut wall and liver. Although domperidone&#39;s bioavailability is enhanced in normal subjects when taken after a meal, patients with gastro-intestinal complaints should take domperidone 15-30 minutes before a meal. Reduced gastric acidity impairs the absorption of domperidone. Oral bioavailability is decreased by prior concomitant administration of cimetidine and sodium bicarbonate. The time of peak absorption is slightly delayed and the AUC somewhat increased when the oral drug is taken after a meal.</p><p><strong><u>Distribution</u></strong></p><p>Oral domperidone does not appear to accumulate or induce its own metabolism; a peak plasma level after 90 minutes of 21 ng/ml after two weeks oral administration of 30 mg per day was almost the same as that of 18 ng/ml after the first dose. Domperidone is 91-93% bound to plasma proteins. Distribution studies with radiolabelled drug in animals have shown wide tissue distribution, but low brain concentration. Small amounts of drug cross the placenta in rats.</p><p><strong><u>Metabolism</u></strong></p><p>Domperidone undergoes rapid and extensive hepatic metabolism by hydroxylation and N-dealkylation.&nbsp;<em>In vitro&nbsp;</em>metabolism experiments with diagnostic inhibitors revealed that CYP3A4 is a major form of cytochrome P-450 involved in the N-dealkylation of domperidone, whereas CYP3A4, CYP1A2 and CYP2E1 are involved in domperidone aromatic hydroxylation.</p><p><strong><u>Excretion</u></strong></p><p>Urinary and faecal excretions amount to 31 and 66% of the oral dose respectively. The proportion of the drug excreted unchanged is small (10% of faecal excretion and approximately 1% of urinary excretion). The plasma half-life after a single oral dose is 7-9 hours in healthy subjects but is prolonged in patients with severe renal insufficiency.</p><p>&nbsp;</p><p><strong><u>Hepatic impairment</u></strong></p><p>In subjects with moderate hepatic impairment (Pugh score 7 to 9, Child-Pugh rating B), the AUC and C<sub>max</sub>&nbsp;of domperidone is 2.9- and 1.5-fold higher, respectively, than in healthy subjects. The unbound fraction is increased by 25%, and the terminal elimination half-life is prolonged from 15 to 23 hours. Subjects with mild hepatic impairment have a somewhat lower systemic exposure than healthy subjects based on C<sub>max</sub>&nbsp;and AUC, with no change in protein binding or terminal half-life. Subjects with severe hepatic impairment were not studied. domperidone is contraindicated in patients with moderate or severe hepatic impairment (see section 4.3).</p><p><strong><u>Renal impairment</u></strong></p><p>In subjects with severe renal insufficiency (creatinine clearance &lt;30ml/min/1.73m<sup>2</sup>) the elimination half-life of domperidone is increased from 7.4 to 20.8 hours, but plasma drug levels are lower than in healthy volunteers. Since very little unchanged drug (approximately 1%) is excreted&nbsp;<em>via</em>&nbsp;the kidneys, it is unlikely that the dose of a single administration needs to be adjusted in patients with renal insufficiency.</p><p>However, on repeated administration, the dosing frequency should be reduced to once or twice daily depending on the severity of the impairment, and the dose may need to be reduced.</p><p><strong><u>Paediatric&nbsp;population</u></strong></p><p>No pharmacokinetic data are available in the paediatric population.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Electrophysiological&nbsp;<em>in vitro</em>&nbsp;and&nbsp;<em>in vivo</em>&nbsp;studies indicate an overall moderate risk of domperidone to prolong the QT interval in humans. In&nbsp;<em>in vitro</em>&nbsp;experiments on isolated cells transfected with hERG and on isolated guinea pig myocytes, exposure ratios ranged between 26- 47-fold, based on IC50 values inhibiting currents through IKr ion channels in comparison to the free plasma concentrations in humans after administration of the maximum daily dose of 10 mg administered 3 times a day. Safety margins for prolongation of action potential duration in&nbsp;<em>in vitro</em>&nbsp;experiments on isolated cardiac tissues exceeded the free plasma concentrations in humans at maximum daily dose (10 mg administered 3 times a day) by 45-fold. Safety margins in&nbsp;<em>in vitro</em>&nbsp;pro-arrhythmic models (isolated Langendorff perfused heart) exceeded the free plasma concentrations in humans at maximum daily dose (10 mg administered 3 times a day) by 9- up to 45-fold. In&nbsp;<em>in vivo</em>&nbsp;models the no effect levels for QTc prolongation in dogs and induction of arrhythmias in a rabbit model sensitized for torsade de pointes exceeded the free plasma concentrations in humans at maximum daily dose (10 mg administered 3 times a day) by more than 22-fold and 435-fold, respectively. In the anesthetized guinea pig model following slow intravenous infusions, there were no effects on QTc at total plasma concentrations of 45.4 ng/mL, which are 3-fold higher than the total plasma levels in humans at maximum daily dose (10 mg administered 3 times a day). The relevance of the latter study for humans following exposure to orally administered domperidone is uncertain.</p><p>In the presence of inhibition of the metabolism via CYP3A4 free plasma concentrations of domperidone can rise up to 3-fold.</p><p>At a high, maternally toxic dose (more than 40 times the recommended human dose), teratogenic effects were seen in the rat. No teratogenicity was observed in mice and rabbits.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:522px"><tbody><tr><td style="vertical-align:top"><p><strong><u>Inactive Ingredients:</u></strong></p></td></tr><tr><td style="vertical-align:top"><ol><li>Sorbitol 70% solution</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Sodium saccharin</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Avicel RC</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Methylparaben</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Propylparaben</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Citric acid monohydrate</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Sodium citrate</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Tween 20 (polysorbate 20)</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Passion fruit flavour</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Purified water</li></ol></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                	Before opening: 24 months from the date of manufacturing
	After opening: one month

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>200mL suspension in type-III amber glass bottle sealed with PP cap, packed in a printed carton along with a measuring cup and a leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gulf Pharmaceutical Industries - Julphar
Digdaga, Airport Street.
Ras Al Khaimah - United Arab Emirates.
P.O. Box 997
Tel. No.: (9717) 2 461 461
Fax No.: (9717) 2 462 462

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                13. September. 2015
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>